-
1
-
-
0034670036
-
The molecular biology of chronic myeloid leukemia
-
Deininger, M. W., Goldman, J. M., and Melo, J. V. The molecular biology of chronic myeloid leukemia. Blood, 96: 3343-3356, 2000.
-
(2000)
Blood
, vol.96
, pp. 3343-3356
-
-
Deininger, M.W.1
Goldman, J.M.2
Melo, J.V.3
-
2
-
-
4243926785
-
Imatinib and chronic myeloid leukemia: Validating the promise of molecularly targeted therapy
-
Druker, B. J. Imatinib and chronic myeloid leukemia: validating the promise of molecularly targeted therapy. Eur. J. Cancer, 38 (Suppl 5): S70-S76, 2002.
-
(2002)
Eur. J. Cancer
, vol.38
, Issue.SUPPL. 5
-
-
Druker, B.J.1
-
3
-
-
0036342294
-
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway
-
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., and Cantley, L. C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell, 10: 151-162, 2002.
-
(2002)
Mol. Cell
, vol.10
, pp. 151-162
-
-
Manning, B.D.1
Tee, A.R.2
Logsdon, M.N.3
Blenis, J.4
Cantley, L.C.5
-
4
-
-
0037131411
-
Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs
-
Zhang, H., Zha, X., Tan, Y., Hornbeck, P. V., Mastrangelo, A. J., Alessi, D. R., Polakiewicz, R. D., and Comb, M. J. Phosphoprotein analysis using antibodies broadly reactive against phosphorylated motifs. J. Biol. Chem., 277: 39379-39387, 2002.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 39379-39387
-
-
Zhang, H.1
Zha, X.2
Tan, Y.3
Hornbeck, P.V.4
Mastrangelo, A.J.5
Alessi, D.R.6
Polakiewicz, R.D.7
Comb, M.J.8
-
5
-
-
0037108448
-
BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90
-
Gorre, M. E., Ellwood-Yen, K., Chiosis, G., Rosen, N., and Sawyers, C. L. BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90. Blood, 100: 3041-3044, 2002.
-
(2002)
Blood
, vol.100
, pp. 3041-3044
-
-
Gorre, M.E.1
Ellwood-Yen, K.2
Chiosis, G.3
Rosen, N.4
Sawyers, C.L.5
-
6
-
-
0034254368
-
Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: Diverse mechanisms of resistance
-
Mahon, F. X., Deininger, M. W., Schultheis, B., Chabrol, J., Reiffers, J., Goldman, J. M., and Melo, J. V. Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance. Blood, 96: 1070-1079, 2000.
-
(2000)
Blood
, vol.96
, pp. 1070-1079
-
-
Mahon, F.X.1
Deininger, M.W.2
Schultheis, B.3
Chabrol, J.4
Reiffers, J.5
Goldman, J.M.6
Melo, J.V.7
-
7
-
-
0016711037
-
High resolution two-dimensional electrophoresis of protein
-
O'Farrell, P. H. High resolution two-dimensional electrophoresis of protein. J. Biol. Chem., 250: 4007-4021, 1975.
-
(1975)
J. Biol. Chem.
, vol.250
, pp. 4007-4021
-
-
O'Farrell, P.H.1
-
8
-
-
0030915898
-
Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k
-
Jefferies, H. B., Fumagalli, S., Dennis, P. B., Reinhard, C., Pearson, R. B., and Thomas, G. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J., 16: 3693-3704, 1997.
-
(1997)
EMBO J.
, vol.16
, pp. 3693-3704
-
-
Jefferies, H.B.1
Fumagalli, S.2
Dennis, P.B.3
Reinhard, C.4
Pearson, R.B.5
Thomas, G.6
-
9
-
-
0032834055
-
eIF4 initiation factors: Effectors of mRNA recruitment to ribosomes and regulators of translation
-
Gingras, A. C., Raught, B., and Sonenberg, N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem., 68: 913-963, 1999.
-
(1999)
Annu. Rev. Biochem.
, vol.68
, pp. 913-963
-
-
Gingras, A.C.1
Raught, B.2
Sonenberg, N.3
-
10
-
-
0036889291
-
Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but requires neither S6K1 nor rpS6 phosphorylation
-
Stolovich, M., Tang, H., Hornstein, E., Levy, G., Cohen, R., Bae, S. S., Birnbaum, M. J., and Meyuhas, O. Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but requires neither S6K1 nor rpS6 phosphorylation. Mol. Cell. Biol., 22: 8101-8113, 2002.
-
(2002)
Mol. Cell. Biol.
, vol.22
, pp. 8101-8113
-
-
Stolovich, M.1
Tang, H.2
Hornstein, E.3
Levy, G.4
Cohen, R.5
Bae, S.S.6
Birnbaum, M.J.7
Meyuhas, O.8
-
11
-
-
0036225178
-
Inhibitors of mammalian target of rapamycin as novel antitumor agents: From bench to clinic
-
Huang, S., and Houghton, P. J. Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic. Curr. Opin. Investig. Drugs, 3: 295-304, 2002.
-
(2002)
Curr. Opin. Investig Drugs
, vol.3
, pp. 295-304
-
-
Huang, S.1
Houghton, P.J.2
-
12
-
-
0037315281
-
Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias
-
Gambacorti-Passerini, C. B., Gunby, R. H., Piazza, R., Galietta, A., Rostagno, R., and Scapozza, L. Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias. Lancet Oncol., 4: 75-85, 2003.
-
(2003)
Lancet Oncol.
, vol.4
, pp. 75-85
-
-
Gambacorti-Passerini, C.B.1
Gunby, R.H.2
Piazza, R.3
Galietta, A.4
Rostagno, R.5
Scapozza, L.6
-
13
-
-
0037438640
-
BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571
-
Donato, N. J., Wu, J. Y., Stapley, J., Gallick, G., Lin, H., Arlinghaus, R., and Talpaz, M. BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571. Blood, 101: 690-698, 2003.
-
(2003)
Blood
, vol.101
, pp. 690-698
-
-
Donato, N.J.1
Wu, J.Y.2
Stapley, J.3
Gallick, G.4
Lin, H.5
Arlinghaus, R.6
Talpaz, M.7
-
14
-
-
0035895106
-
Restoration of sensitivity to STI571 in STI571-resistant chronic myeloid leukemia cells
-
Tipping, A. J., Mahon, F. X., Lagarde, V., Goldman, J. M., and Melo, J. V. Restoration of sensitivity to STI571 in STI571-resistant chronic myeloid leukemia cells. Blood, 98: 3864-3867, 2001.
-
(2001)
Blood
, vol.98
, pp. 3864-3867
-
-
Tipping, A.J.1
Mahon, F.X.2
Lagarde, V.3
Goldman, J.M.4
Melo, J.V.5
-
15
-
-
0036736514
-
Interleukin-3 protects Bcr-Abl-transformed hematopoietic progenitor cells from apoptosis induced by Bcr-Abl tyrosine kinase inhibitors
-
Dorsey, J. F., Cunnick, J. M., Lanehart, R., Huang, M., Kraker, A. J., Bhalla, K. N., Jove, R., and Wu, J. Interleukin-3 protects Bcr-Abl-transformed hematopoietic progenitor cells from apoptosis induced by Bcr-Abl tyrosine kinase inhibitors. Leukemia (Baltimore), 16: 1589-1595, 2002.
-
(2002)
Leukemia (Baltimore)
, vol.16
, pp. 1589-1595
-
-
Dorsey, J.F.1
Cunnick, J.M.2
Lanehart, R.3
Huang, M.4
Kraker, A.J.5
Bhalla, K.N.6
Jove, R.7
Wu, J.8
-
16
-
-
0037126385
-
Jak2 is involved in c-Myc induction by Bcr-Abl
-
Xie, S., Lin, H., Sun, T., and Arlinghaus, R. B. Jak2 is involved in c-Myc induction by Bcr-Abl. Oncogene, 21: 7137-7146, 2002.
-
(2002)
Oncogene
, vol.21
, pp. 7137-7146
-
-
Xie, S.1
Lin, H.2
Sun, T.3
Arlinghaus, R.B.4
-
17
-
-
0032999830
-
Target of rapamycin (TOR): Balancing the opposing forces of protein synthesis and degradation
-
Dennis, P. B., Fumagalli, S., and Thomas, G. Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. Curr. Opin. Genet. Dev., 9: 49-54, 1999.
-
(1999)
Curr. Opin. Genet. Dev.
, vol.9
, pp. 49-54
-
-
Dennis, P.B.1
Fumagalli, S.2
Thomas, G.3
-
18
-
-
0030013326
-
Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase
-
Mendez, R., Myers, M. G., Jr., White, M. F., and Rhoads, R. E. Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase. Mol. Cell. Biol., 16: 2857-2864, 1996.
-
(1996)
Mol. Cell. Biol.
, vol.16
, pp. 2857-2864
-
-
Mendez, R.1
Myers M.G., Jr.2
White, M.F.3
Rhoads, R.E.4
-
19
-
-
0032491579
-
Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway
-
Muise-Helmericks, R. C., Grimes, H. L., Bellacosa, A., Malstrom, S. E., Tsichlis, P. N., and Rosen, N. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem., 273: 29864-29872, 1998.
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 29864-29872
-
-
Muise-Helmericks, R.C.1
Grimes, H.L.2
Bellacosa, A.3
Malstrom, S.E.4
Tsichlis, P.N.5
Rosen, N.6
-
20
-
-
0026788001
-
Dominant negative MYC blocks transformation by ABL oncogenes
-
Sawyers, C. L., Callahan, W., and Witte, O. N. Dominant negative MYC blocks transformation by ABL oncogenes. Cell, 70: 901-910, 1992.
-
(1992)
Cell
, vol.70
, pp. 901-910
-
-
Sawyers, C.L.1
Callahan, W.2
Witte, O.N.3
-
21
-
-
0028857940
-
Signaling by ABL oncogenes through cyclin D1
-
Afar, D. E., McLaughlin, J., Sherr, C. J., Witte, O. N., and Roussel, M. F. Signaling by ABL oncogenes through cyclin D1. Proc. Natl. Acad. Sci. USA, 92: 9540-9544, 1995.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 9540-9544
-
-
Afar, D.E.1
McLaughlin, J.2
Sherr, C.J.3
Witte, O.N.4
Roussel, M.F.5
-
22
-
-
0037049762
-
Post-transcriptional mechanisms in BCR/ABL leukemogenesis: Role of shuttling RNA-binding proteins
-
Perrotti, D., and Calabretta, B. Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins. Oncogene, 21: 8577-8583, 2002.
-
(2002)
Oncogene
, vol.21
, pp. 8577-8583
-
-
Perrotti, D.1
Calabretta, B.2
-
23
-
-
0030710188
-
Transformation of hematopoietic cells by BCR/ABL requires activation of a P1-3k/Akt-dependent pathway
-
Skorski, T., Bellacosa, A., Nieborowska-Skorska, M., Majewski, M., Martinez, R., Choi, J. K., Trotta, R., Wlodarski, P., Perrotti, D., Chan, T. O., Wasik, M. A., Tsichlis, P. N., and Calabretta, B. Transformation of hematopoietic cells by BCR/ABL requires activation of a P1-3k/Akt-dependent pathway. EMBO J., 16: 6151-6161, 1997.
-
(1997)
EMBO J.
, vol.16
, pp. 6151-6161
-
-
Skorski, T.1
Bellacosa, A.2
Nieborowska-Skorska, M.3
Majewski, M.4
Martinez, R.5
Choi, J.K.6
Trotta, R.7
Wlodarski, P.8
Perrotti, D.9
Chan, T.O.10
Wasik, M.A.11
Tsichlis, P.N.12
Calabretta, B.13
-
24
-
-
0036683409
-
Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336
-
Hoover, R. R., Mahon, F. X., Melo, J. V., and Daley, G. Q. Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336. Blood, 100: 1068-1071, 2002.
-
(2002)
Blood
, vol.100
, pp. 1068-1071
-
-
Hoover, R.R.1
Mahon, F.X.2
Melo, J.V.3
Daley, G.Q.4
|